Spanish Validation Of Quality of Life Questionnaire (QOLIE-10) For Epilepsy

GlaxoSmithKline (GSK)

Status: Completed

Conditions: Epilepsy

Treatments: Drug: valproic acid; Drug: lamotrigine

Study type: Observational

Funder types: Industry

Identifiers

NCT00264680

LAM-2003-01

Details and patient eligibility

About

Validation of qolie-10, an epilepsy specific quality of life questionnaire in patients treated with lamotrigine or valproic acid. Comparison of quality of life of epileptic patients treated with lamotrigine or valproic acid. Determination and assessment of the comparative safety of lamotrigine or valproic acid. Assessment and comparison of body image perception in women treated with lamotrigine or valproic acid.

Enrollment: 333 patients

Sex: All

Ages: 18 to 50 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of epilepsy and normal neurological examination.
• Patients receiving lamotrigine or valproic acid at stable doses in monotherapy initiated 2 -4 months before.

Exclusion criteria

• Pregnant or lactating women.
• Previous treatment with lamotrigine or valproic acid.
• Secondary epilepsy.